fragmin injection 10000 iuml
pfizer private limited - dalteparin sodium - injection - 10000 iu/ml - dalteparin sodium 10000 iu/ml
fragmin injection 2500 iu0.2 ml
pfizer private limited - dalteparin sodium - injection - 2500 iu/0.2 ml - dalteparin sodium 2500 iu/0.2 ml
fragmin injection 2500 iuml
pfizer private limited - dalteparin sodium - injection - 2500 iu/ml - dalteparin sodium 2500 iu/ml
fragmin injection 5000 iu0.2 ml
pfizer private limited - dalteparin sodium - injection - 5000 iu/0.2 ml - dalteparin sodium 5000 iu/0.2 ml
bridion solution for injection 100mgml
msd pharma (singapore) pte. ltd. - sugammadex sodium 108.8mg eqv sugammadex - injection, solution - 100mg - sugammadex sodium 108.8mg eqv sugammadex 100mg
anacal rectal ointment
genus pharmaceuticals limited linthwaite, huddersfied hd7 5qh, united kingdom - mucopolysaccharide polysulfuric, acid ester, lauromacrogol - rectal ointment - mucopolysaccharide polysulfuric acid ester 0.2 % (w/w) lauromacrogol 400 5 % (w/w) - vasoprotectives
anacal suppositories
genus pharmaceuticals limited linthwaite, huddersfied hd7 5qh, united kingdom - mucopolysaccharide polysulfuric, acid ester, lauromacrogol - suppository - mucopolysaccharide polysulfuric acid ester 4 mg lauromacrogol 400 50 mg - vasoprotectives
ropivacaine sandoz ropivacaine hydrochloride (as monohydrate) 200mg/100ml solution for injection infusion bag
sandoz pty ltd - ropivacaine hydrochloride, quantity: 2 mg/ml - injection, solution - excipient ingredients: water for injections; sodium hydroxide; hydrochloric acid; sodium chloride - surgical anaesthesia (adults and children over 12 years of age). - epidural block for surgery including caesarean section. - intrathecal anaesthesia. - field block (minor nerve block and infiltration). - major nerve block. analgesia (adults and children over 12 years of age). - continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain. - field block (minor nerve block and infiltration). - continuous peripheral nerve block infusion or intermittent injections for post operative pain management. analgesia (children aged 0 - 12 years). - caudal epidural block in neonates (> 37 weeks gestation and over 2500 g weight), infants and children up to and including 12 years . - continuous epidural infusion in infants (> 30 days and over 2500 g weight) and children up to and including 12 years. - peripheral nerve block in children aged 1 up to and including 12 years. for peri- and postoperative pain management. there are no safety or efficacy data to support the use of ropivacaine for analgesia for longer than 72 hours. (data for peripheral nerve block administered as a continuous peripheral infusion or intermittent injections support the use for up to 48 hours only).
ropivacaine sandoz ropivacaine hydrochloride (as monohydrate) 100mg/20ml solution for injection ampoule
sandoz pty ltd - ropivacaine hydrochloride, quantity: 5 mg/ml - injection, solution - excipient ingredients: water for injections; sodium chloride; hydrochloric acid; sodium hydroxide - surgical anaesthesia (adults and children over 12 years of age). - epidural block for surgery including caesarean section. - intrathecal anaesthesia. - field block (minor nerve block and infiltration). - major nerve block. analgesia (adults and children over 12 years of age). - continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain. - field block (minor nerve block and infiltration). - continuous peripheral nerve block infusion or intermittent injections for post operative pain management. analgesia (children aged 0 - 12 years). - caudal epidural block in neonates (> 37 weeks gestation and over 2500 g weight), infants and children up to and including 12 years . - continuous epidural infusion in infants (> 30 days and over 2500 g weight) and children up to and including 12 years. - peripheral nerve block in children aged 1 up to and including 12 years. for peri- and postoperative pain management. there are no safety or efficacy data to support the use of ropivacaine for analgesia for longer than 72 hours. (data for peripheral nerve block administered as a continuous peripheral infusion or intermittent injections support the use for up to 48 hours only).
ropivacaine sandoz ropivacaine hydrochloride (as monohydrate) 50mg/10ml solution for injection ampoule
sandoz pty ltd - ropivacaine hydrochloride, quantity: 5 mg/ml - injection, solution - excipient ingredients: hydrochloric acid; sodium chloride; sodium hydroxide; water for injections - surgical anaesthesia (adults and children over 12 years of age). - epidural block for surgery including caesarean section. - intrathecal anaesthesia. - field block (minor nerve block and infiltration). - major nerve block. analgesia (adults and children over 12 years of age). - continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain. - field block (minor nerve block and infiltration). - continuous peripheral nerve block infusion or intermittent injections for post operative pain management. analgesia (children aged 0 - 12 years). - caudal epidural block in neonates (> 37 weeks gestation and over 2500 g weight), infants and children up to and including 12 years . - continuous epidural infusion in infants (> 30 days and over 2500 g weight) and children up to and including 12 years. - peripheral nerve block in children aged 1 up to and including 12 years. for peri- and postoperative pain management. there are no safety or efficacy data to support the use of ropivacaine for analgesia for longer than 72 hours. (data for peripheral nerve block administered as a continuous peripheral infusion or intermittent injections support the use for up to 48 hours only).